When Disruptive Innovation Transforms Into Established AF Therapy: Reality check With 1 Million Patients Treated Using Medtronic Cryoablation Technology
Experts in electrophysiology will present how the Arctic Front™ Cardiac Cryoablation Catheter System transformed from a disruptive innovation into an established AF therapy and showcase the latest clinical evidence.
The presenters will each draw on their clinical experience, for an in-depth discussion on improvements and patient safety in Cryoballoon AF ablation. Finally, the faculty will share practical advice from the mission towards a risk-free AF ablation with Cryoballoon.
The first Arctic Front™ Cardiac Cryoablation procedure took place in 2005, and since then, over 1,000,000 patients have been treated with Medtronic Cryoablation worldwide. The efficiency benefits of this unique single-shot therapy are obvious and well documented in more than 1,200 peer-reviewed scientific articles. The results of the landmark FIRE AND ICE, CRYO4PERSISTENT AF and EARLY-AF trials highlight an important global shift to value-based healthcare, measured by the ability to standardize the index PVI procedure. The impact on patient outcomes as well as the economic value for the global healthcare systems is significant.
This webinar is supported by:
PART 1 – Welcome & Introduction
PART 2 – A disruptive innovation transforming into an established AF therapy: Arctic Front Advance Pro™ Cryoballoon
PART 3 – Mission towards a risk-free AF ablation with Cryoballoon
PART 4 – Live Q&A
PART 5 – Closing Remarks
Key Learning Objectives
- Journey how Arctic Front™ Cardiac Cryoablation Catheter System transformed from a disruptive innovation into an established AF therapy
- Latest evidence updates on Medtronic Cryoballoon ablation therapy developed from different perspectives
- Cryo biophysics and patient tailored AF treatment with Arctic Front™ Cardiac Cryoablation Catheter System
- Safety of AF ablation therapy with Medtronic Cryoballoon
- Cardiac electrophysiologists and allied health professionals performing and assisting during Cryoballoon AF ablation procedures.
- Healthcare professionals using alternative AF ablation techniques.
- Referring healthcare professionals treating AF patients will also find this topical.
Prof Karl-Heinz Kuck is the Medical Director at LANS Cardio Hamburg. For many years, he was head of the Department of Cardiology at the Asklepios Klinik St. Georg in Hamburg. In addition, Prof Kuck was President of the European Heart Rhythm Association and President of the German Society for Cardiology.
He has earned several prizes for his work, including the Science Prize of the Gertrud Spitz Foundation and a silver badge of honor from the German Society for Cardiology – Heart and Circulatory Research. Prof Dr Kuck is also Section Editor – Clinical Electrophysiology and Ablation at Arrhythmia & Electrophysiology Review.
Prof Kuck is on the AER editorial board.
Professor Ross Jacob Hunter was born in 1977 in the UK. He is a Consultant Cardiologist specialising in arrhythmia management and the clinical lead for AF services at The Barts Heart Centre.3
Prof Hunter earned his BSc in Cardiovascular Medicine from Imperial College London in 1998. In 2001, he was awarded an MBBS with a distinction from Guy’s Kings & St Thomas and his MRCP from the Royal College of Physicians in 2004.2
In 2013, he completed his PhD from the Queen Mary University of London in the field of Clinical Cardiac Electrophysiology with a thesis focused on catheter ablation of atrial fibrillation. That year, he was also awarded a Certificate of Completion of Training (CCT) from the London Deanery for Postgraduate Medical Education.2
Prof Hunter is active in clinical research. He runs clinical trials in cardiac electrophysiology, particularly related to catheter ablation of AF, frequently collaborating with other scientists in a variety of disciplines. His current research investigates the mechanisms and treatment of cardiac arrhythmias.1
Prof Hunter is the atrial fibrillation lead at St Bartholomew’s Hospital, the largest cardiac centre in Europe. He trains doctors to perform the catheter ablation procedure and implant pacemakers. He is also the lead for the Barts arrhythmia courses and supervises PhD students.1 Prof Hunter is also a Reader at the Queen Mary University of London.1, 2
His private practice is at The London AF Centre (London Bridge Hospital), a leading private centre focusing on AF management.2
His focus is almost exclusively on heart rhythm, performing over 200 complex ablation procedures per year, using the full range of equipment such as 3D mapping systems, cryoballoons and robotics.1
Prof Hunter is Editor-in-Chief of Cardiac Rhythm News, a journal bringing the latest scientific advances and industry news to clinicians. He is also a reviewer for Circulation: Arrhythmia & Electrophysiology; Journal of the American Heart Association and the British Medical Journal.1
He is a Member of the British Heart Rhythm Society and a Fellow of The European Society of Cardiology. Prof Hunter has published widely on atrial fibrillation and other areas of heart rhythm management in peer-reviewed journals and has edited six books.1
- 2005 - 2013: Cardiology Registrar, NHS
- 2013 - Present: Reader Cardiac Electrophysiology, Queen Mary, University of London
- 2013 - Present: Editor in Chief, Cardiac Rhythm News
- 2013 - Present: Consultant Cardiologist, Electrophysiologist and AF Lead, The Barts Heart Centre
- 2014 - Present: Consultant Cardiologist and Electrophysiologist, The London Bridge Hospital
Areas of Speciality
- Complex Devices
- Atrial Fibrillation
- 2017: Arrhythmia Alliance Team of the Year Award, Arrhythmia Alliance
- 2016: Pioneers in Health Care Award, AF Association
- 2011: Finalist & Runner up for Young Investigator of the Year Award in both UK and USA, Heart Rhythm Society (USA) and British Heart Rhythm Society (BHRS)
Prof Chierchia has been Director of the Atrial Fibrillation Program at the Heart Rhythm Management Institute of the Vrije Universtair Ziekenhuis of Brussels, directed by Prof Pedro Brugada, since 2007. He completed his training at the University of Milan, Italy.